james-hilbert documents

Company presentation
Documents Company presentation
Clda bmo01
Documents Clda bmo01
Phase 2b emerge study of cdx 011
Health & Medicine Phase 2b emerge study of cdx 011
Bmn 110 ph12 results
Business Bmn 110 ph12 results
Docetaxel Versus Docetaxel/Cisplatin in NSCLC
Health & Medicine Docetaxel Versus Docetaxel/Cisplatin in NSCLC
GS Weekly Options Watch - May 11th
Business GS Weekly Options Watch - May 11th
12702889
Documents 12702889
Lovenox trial scheduling
Documents Lovenox trial scheduling
$SNGX Nnational.2.1.2010
Business $SNGX Nnational.2.1.2010
Optr 03292011
Documents Optr 03292011
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease (Review)
Health & Medicine Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease (Review)
Clda roth01
Documents Clda roth01
Goldman mnta
Documents Goldman mnta
Astm restore cli update nov 2010
Documents Astm restore cli update nov 2010
Clda griffin01
Documents Clda griffin01
Novel therapies in hcc
Business Novel therapies in hcc
Inhx buy nov 2010
Documents Inhx buy nov 2010
5 understanding some basic trial designs in sarcomas (inclusive a placebo one) prof van der graaf nl
Documents 5 understanding some basic trial designs in sarcomas (inclusive a placebo one) prof van der graaf nl
Asco 2012 abstract_45010_oral_final
Documents Asco 2012 abstract_45010_oral_final
Transforming time for prostate cancer therapies
Economy & Finance Transforming time for prostate cancer therapies
Dcth isolation perfusion
Documents Dcth isolation perfusion